Skip to main content

Table 2 Anti-CCP2 antibodies and RF in RA and non-RA patients and normal controls.

From: Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

Disease (n) anti-CCP (%) RF (%)
Rheumatoid arthritis (155) 98 (63.2) 92 (59,1)
Spondyloarthropathies (53) 2 (3.8) 5 (9.4)
Systemic lupus erythematosus (32) 2 (6.2) 6 (18.7)
Sjogren's syndrome (17) 3 (17.6) 3 (17.6)
Osteoarthritis (19) 0 (0.0) 0 (0.0)
Vasculitis (15) 3 (20) 4 (26.7)
Polymyalgia rheumatica (11) 0 (0.0) 0 (0.0)
Crystal arthritis (7) 0 (0.0) 1 (14.3)
Adult onset Still's disease (5) 0 (0.0) 0 (0.0)
Systemic sclerosis (5) 1 (20) 1 (20)
Juvenile idiopathic arthritis (4) 1 (25) 1 (25)
Brucellosis (4) 2 (50) 1 (25)
Others (n = 6) 0 (0.0) 0 (0.0)
Normal controls (100) 0 (0.0) 3 (3.0)
  1. Others = mixed connective tissue disease, familial Mediterranean fever, rheumatic fever, dermatomyositis, anti-phospholipid syndrome.